Enrik John T. Aguila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Enrik John T. Aguila has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Ian Homer Y. Cua
Institute of Digestive and Liver Diseases, St. Luke's Medical Center Global City, Taguig City, Philippines
8 shared publicationsCarlos Paolo D. Francisco
Institute of Digestive and Liver Diseases, St. Luke's Medical Center Global City, Philippines
3 shared publicationsRajvinder Singh
Department of Gastroenterology and Hepatology Lyell McEwin Hospital, SA Health Elizabeth Vale South Australia Australia
3 shared publicationsAndrawus Beany
Department of Gastroenterology and Hepatology Lyell McEwin Hospital, SA Health Elizabeth Vale South Australia Australia
2 shared publications- Carlos Paolo D. Francisco
Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore
2 shared publications Joy Arabelle C. Fontanilla
Center for Weight Intervention and Nutrition Services St Luke's Medical Center Global City Manila Philippines
2 shared publications
Latest Publications
- 23 February 2026
- Published by Elsevier in Gastroenterology
- Vol. 171 (1) , 18-23
Visualizing Science in Gastroenterology: The Role of Infographics and Graphical Abstracts in Education, Communication, and Research Dissemination
- 23 February 2026
- Published by Elsevier in Gastroenterology
- Vol. 171 (1) , 18-23
Visualizing Science in Gastroenterology: The Role of Infographics and Graphical Abstracts in Education, Communication, and Research Dissemination
- 17 December 2025
- Published by BMJ in Frontline Gastroenterology
Cold snare versus hot snare endoscopic mucosal resection of large non-pedunculated colorectal adenomas and serrated lesions: a systematic review and meta-analysis
Objective: Hot snare endoscopic mucosal resection (H-EMR) is traditionally used for resecting large non-pedunculated colorectal polyps (LNPCPs) but carries thermal-injury risks. Cold snare EMR (C-EMR) avoids electrocautery and may be safer. We compared efficacy, recurrence and safety of C-EMR versus H-EMR for adenomatous and serrated lesions ≥15 mm, with prespecified histology analyses. Design/method: A systematic review and meta-analysis was conducted up to May 2025. Seven comparative studies (four randomised controlled trials; three observational) including 2898 LNPCPs (C-EMR 1029; H-EMR 1869) met criteria. Random-effects models produced pooled risk ratios/ORs with 95% CIs. Prespecified subgroups evaluated adenomas versus sessile serrated lesions (SSLs). Results: Technical success was similar (96.3% vs 98.7%; OR 0.46, 95% CI (0.13 to 1.64); p=0.23). Overall recurrence was higher with C-EMR (23.6% vs 11.7%); RR 1.90, 95% CI (1.30 to 2.78); p<0.001. By histology, recurrence was higher for adenomas with C-EMR (26.0% vs 14.7%); RR 1.90, 95% CI (1.30 to 2.79); p<0.001, but not for SSLs (5.1% vs 4.2%); RR 1.30, 95% CI (0.54 to 3.55); p=0.50. Safety favoured C-EMR: intraprocedural bleeding (9.5% vs 10.1%; RR 0.66, 95% CI (0.46 to 0.95); p<0.05), delayed bleeding (1.0% vs 4.4%; RR 0.39, 95% CI (0.20 to 0.74); p<0.01) and perforation (0% vs 1.5%; RR 0.22, 95% CI (0.06 to 0.81); p<0.05) were all lower. Conclusions: Both techniques are effective. For adenomatous LNPCPs, H-EMR lowers recurrence at the cost of more adverse events. For SSLs and in higher risk patients, C-EMR’s superior safety profile supports it as the preferred approach; recurrence differences for SSLs were not significant.
- 17 December 2025
- Published by BMJ in Frontline Gastroenterology
Cold snare versus hot snare endoscopic mucosal resection of large non-pedunculated colorectal adenomas and serrated lesions: a systematic review and meta-analysis
Objective: Hot snare endoscopic mucosal resection (H-EMR) is traditionally used for resecting large non-pedunculated colorectal polyps (LNPCPs) but carries thermal-injury risks. Cold snare EMR (C-EMR) avoids electrocautery and may be safer. We compared efficacy, recurrence and safety of C-EMR versus H-EMR for adenomatous and serrated lesions ≥15 mm, with prespecified histology analyses. Design/method: A systematic review and meta-analysis was conducted up to May 2025. Seven comparative studies (four randomised controlled trials; three observational) including 2898 LNPCPs (C-EMR 1029; H-EMR 1869) met criteria. Random-effects models produced pooled risk ratios/ORs with 95% CIs. Prespecified subgroups evaluated adenomas versus sessile serrated lesions (SSLs). Results: Technical success was similar (96.3% vs 98.7%; OR 0.46, 95% CI (0.13 to 1.64); p=0.23). Overall recurrence was higher with C-EMR (23.6% vs 11.7%); RR 1.90, 95% CI (1.30 to 2.78); p<0.001. By histology, recurrence was higher for adenomas with C-EMR (26.0% vs 14.7%); RR 1.90, 95% CI (1.30 to 2.79); p<0.001, but not for SSLs (5.1% vs 4.2%); RR 1.30, 95% CI (0.54 to 3.55); p=0.50. Safety favoured C-EMR: intraprocedural bleeding (9.5% vs 10.1%; RR 0.66, 95% CI (0.46 to 0.95); p<0.05), delayed bleeding (1.0% vs 4.4%; RR 0.39, 95% CI (0.20 to 0.74); p<0.01) and perforation (0% vs 1.5%; RR 0.22, 95% CI (0.06 to 0.81); p<0.05) were all lower. Conclusions: Both techniques are effective. For adenomatous LNPCPs, H-EMR lowers recurrence at the cost of more adverse events. For SSLs and in higher risk patients, C-EMR’s superior safety profile supports it as the preferred approach; recurrence differences for SSLs were not significant.
- Open Access
- 30 January 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (1) , 144-146
Delayed gastric emptying and microorganisms in tetrads
Delayed gastric emptying and microorganisms in tetrads
- 30 January 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (1) , 144-146
Open AccessDelayed gastric emptying and microorganisms in tetrads
Delayed gastric emptying and microorganisms in tetrads
- Open Access
Exploring vision transformers for classifying early Barrett's dysplasia in endoscopic images: A pilot study on white‐light and narrow‐band imaging
Background and Aim: Various deep learning models, based on convolutional neural network (CNN), have been shown to improve the detection of early esophageal neoplasia in Barrett's esophagus. Vision transformer (ViT), derived from natural language processing, has emerged as the new state‐of‐the‐art for image recognition, outperforming predecessors such as CNN. This pilot study explores the use of ViT to classify the presence or absence of early esophageal neoplasia in endoscopic images of Barrett's esophagus.Methods: A BO dataset of 1918 images of Barrett's esophagus from 267 unique patients was used. The images were classified as dysplastic (D‐BO) or non‐dysplastic (ND‐BO). A pretrained vision transformer model, ViTBase16, was used to develop our classifier models. Three ViT models were developed for comparison based on imaging modality: white‐light imaging (WLI), narrow‐band imaging (NBI), and combined modalities. Performance of each model was evaluated based on accuracy, sensitivity, specificity, confusion matrices, and receiver operating characteristic curves.Results: The ViT models demonstrated the following performance: WLI‐ViT (Accuracy: 92%, Sensitivity: 82%, Specificity: 95%), NBI‐ViT (Accuracy: 99%, Sensitivity: 97%, Specificity: 99%), and combined modalities‐ViT (Accuracy: 93%, Sensitivity: 87%, Specificity: 95%). Combined modalities‐ViT showed greater accuracy (94% vs 90%) and sensitivity (80% vs 70%) compared with WLI‐ViT when classifying WLI images on a subgroup testing set.Conclusion: ViT exhibited high accuracy in classifying the presence or absence of EON in endoscopic images of Barrett's esophagus. ViT has the potential to be widely applicable to other endoscopic diagnoses of gastrointestinal diseases.
Open AccessExploring vision transformers for classifying early Barrett's dysplasia in endoscopic images: A pilot study on white‐light and narrow‐band imaging
Background and Aim: Various deep learning models, based on convolutional neural network (CNN), have been shown to improve the detection of early esophageal neoplasia in Barrett's esophagus. Vision transformer (ViT), derived from natural language processing, has emerged as the new state‐of‐the‐art for image recognition, outperforming predecessors such as CNN. This pilot study explores the use of ViT to classify the presence or absence of early esophageal neoplasia in endoscopic images of Barrett's esophagus.Methods: A BO dataset of 1918 images of Barrett's esophagus from 267 unique patients was used. The images were classified as dysplastic (D‐BO) or non‐dysplastic (ND‐BO). A pretrained vision transformer model, ViTBase16, was used to develop our classifier models. Three ViT models were developed for comparison based on imaging modality: white‐light imaging (WLI), narrow‐band imaging (NBI), and combined modalities. Performance of each model was evaluated based on accuracy, sensitivity, specificity, confusion matrices, and receiver operating characteristic curves.Results: The ViT models demonstrated the following performance: WLI‐ViT (Accuracy: 92%, Sensitivity: 82%, Specificity: 95%), NBI‐ViT (Accuracy: 99%, Sensitivity: 97%, Specificity: 99%), and combined modalities‐ViT (Accuracy: 93%, Sensitivity: 87%, Specificity: 95%). Combined modalities‐ViT showed greater accuracy (94% vs 90%) and sensitivity (80% vs 70%) compared with WLI‐ViT when classifying WLI images on a subgroup testing set.Conclusion: ViT exhibited high accuracy in classifying the presence or absence of EON in endoscopic images of Barrett's esophagus. ViT has the potential to be widely applicable to other endoscopic diagnoses of gastrointestinal diseases.
- 3 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 163 (5) , e10-e11
Unusual White Esophageal Patches With Cobblestone Appearance
- 3 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 163 (5) , e10-e11
Unusual White Esophageal Patches With Cobblestone Appearance
- 30 July 2021
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 24 (5) , 440-445
Effects of coronavirus disease 2019 on the digestive system and its nutritional implications
Purpose of review: There has been a deluge of scientific data since coronavirus disease 2019 (COVID-19) was first reported. The effects of COVID-19 on the digestive system are now increasingly well understood. This article aims to review the current data on the effects of COVID-19 on the digestive system with particular emphasis on preexisting digestive diseases and its implications on nutrition practices. Recent findings: Evidence has shown that Severe acute respiratory syndrome coronavirus 2 virus affects the gastrointestinal (GI) tract, pancreas and hepatobiliary system resulting in different GI manifestations. Several preexisting digestive diseases have been investigated. These studies have revealed that these special patient population groups are generally not at an increased risk to contract COVID-19, but are susceptible to develop increasing severity of disease. Aside from medical therapy, optimizing nutritional care has a beneficial role in this group of patients. Summary: GI manifestations of COVID-19 in addition to preexisting digestive diseases have an impact on patient's nutrition. Digestion, absorption and transport of nutrients may be impaired. To date, there are no existing guidelines on the nutritional management of patients for this particular at-risk group. Most nutrition practices are based only on observations and clinical experience. Basic prepandemic nutrition care principles are primarily followed but often individualized based on clinical judgment.
- 30 July 2021
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 24 (5) , 440-445
Effects of coronavirus disease 2019 on the digestive system and its nutritional implications
Purpose of review: There has been a deluge of scientific data since coronavirus disease 2019 (COVID-19) was first reported. The effects of COVID-19 on the digestive system are now increasingly well understood. This article aims to review the current data on the effects of COVID-19 on the digestive system with particular emphasis on preexisting digestive diseases and its implications on nutrition practices. Recent findings: Evidence has shown that Severe acute respiratory syndrome coronavirus 2 virus affects the gastrointestinal (GI) tract, pancreas and hepatobiliary system resulting in different GI manifestations. Several preexisting digestive diseases have been investigated. These studies have revealed that these special patient population groups are generally not at an increased risk to contract COVID-19, but are susceptible to develop increasing severity of disease. Aside from medical therapy, optimizing nutritional care has a beneficial role in this group of patients. Summary: GI manifestations of COVID-19 in addition to preexisting digestive diseases have an impact on patient's nutrition. Digestion, absorption and transport of nutrients may be impaired. To date, there are no existing guidelines on the nutritional management of patients for this particular at-risk group. Most nutrition practices are based only on observations and clinical experience. Basic prepandemic nutrition care principles are primarily followed but often individualized based on clinical judgment.
- 1 April 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (5) , 1889-1890
The Dilemma in the Management of Gastrointestinal Bleeding During the COVID-19 Pandemic
- 1 April 2021
- Published by Elsevier in Gastroenterology
- Vol. 160 (5) , 1889-1890
The Dilemma in the Management of Gastrointestinal Bleeding During the COVID-19 Pandemic
- 12 February 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 36 (2) , 498-499
Response to “High‐Fat Diet, Hypertriglyceridemia, Hyperlipidemic Acute Pancreatitis: Don't Forget Novel Coronavirus–Induced Acute Pancreatitis”
- 12 February 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 36 (2) , 498-499
Response to “High‐Fat Diet, Hypertriglyceridemia, Hyperlipidemic Acute Pancreatitis: Don't Forget Novel Coronavirus–Induced Acute Pancreatitis”
- 1 February 2021
- Published by Elsevier in Clinical Nutrition
- Vol. 40 (2) , 655-656
Different barriers to nutritional therapy among critically-ill patients with COVID-19
- 1 February 2021
- Published by Elsevier in Clinical Nutrition
- Vol. 40 (2) , 655-656
Different barriers to nutritional therapy among critically-ill patients with COVID-19
- 1 January 2021
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 23 (4) , 328-335
How to Approach Small Polyps in Colon: Tips and Tricks
- 1 January 2021
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 23 (4) , 328-335
How to Approach Small Polyps in Colon: Tips and Tricks